Nanophase reports record Q2 revenue $11.9M, up 10% YoY; sees Q3 profit

SOLESENCE, INC.

2023-Q2 EPS reported -$0.02 revenue$21,329,000

Q2 revenue $11.9M (+10% product revenue YoY); H1 revenue $21.3M (+12% product revenue YoY)
Gross margin 31% in Q2, up from prior periods; net income before litigation costs 7% (Q2) and 1% (YTD)
Expects Q3 profit and modest full-year profit; $15M in open orders/P.O.s, >2/3 for Q3 volume
Won Cosmopack Formulation Award in July for Natural Glow Face Oil SPF 40+; Harrison King joined as VP manufacturing
First fully automated filling line validated, increasing capacity 200% with no additional labor costs

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SOLESENCE, INC. reported second quarter ended June 30, 2023 results: revenue $11.9 million.

Period: second quarter ended June 30, 2023
Revenue: $11.9 million
Result: reported results

Exact text from the filing

Revenue for Q2 was $11.9 million, vs. $11.2 million for the same period in 2022, yielding a 10% increase in product revenue and a 6% increase overall.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

SOLESENCE, INC. filing history →

Source: SEC EDGAR

accession 0001171843-23-004897

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.